Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome

Risk Factors for Neurodevelopmental Disability

Genetic disorders or syndromes may be found in up to 30% of pediatric patients with congenital heart disease and significantly impact neurodevelopmental outcomes, according to the American Heart Association 1, 2
Premature infants (less than 37 weeks), especially those born weighing less than 1500g, are at increased risk for developmental delay, as stated by the American Academy of Pediatrics 3
Significant abnormalities on neuroimaging or microcephaly are associated with neurodevelopmental disabilities in children with hypoplastic left heart syndrome 3
Alterations in cerebral blood flow in fetuses with complex congenital heart disease and impaired volumetric brain growth in third-trimester fetuses with congenital heart disease contribute to developmental issues, as reported by the American College of Cardiology 4

Prolonged hospitalization (postoperative length of stay >2 weeks) is associated with poorer outcomes in children with hypoplastic left heart syndrome, according to the Society of Thoracic Surgeons 5
History of mechanical support (ECMO or VAD use) increases risk for developmental disorders in pediatric patients with congenital heart disease, as stated by the Extracorporeal Life Support Organization 5

Early identification of genetic syndromes is crucial for risk stratification and intervention planning in children with hypoplastic left heart syndrome, as recommended by the American Heart Association 1, 2
Children with hypoplastic left heart syndrome should be categorized as high-risk for developmental disorders based on American Heart Association guidelines 1
Regular neurodevelopmental surveillance, screening, and evaluation are essential for patients with congenital heart disease, as emphasized by the American Academy of Pediatrics 4
Early intervention services should be considered for all hypoplastic left heart syndrome patients, particularly those with genetic syndromes, as suggested by the American College of Cardiology 5

Premature infants (less than 37 weeks), especially late-preterm infants (34-36 weeks), are at significantly increased risk for developmental delay compared to term infants 6
Lower gestational age is directly associated with developmental disabilities in the complex CHD population 6
Recent studies have demonstrated that delivery of neonates with critical CHD before 39 weeks' gestation is associated with greater mortality, morbidity, and resource use at progressively earlier gestational ages 6
The American Heart Association guidelines emphasize patient-specific characteristics like prematurity over surgical timing when assessing neurodevelopmental risk 7, 6

Premature infants with HLHS require heightened developmental screening and evaluation 6
The combination of prematurity and complex CHD creates a compounded risk for neurodevelopmental disability 6, 8

Brain maturation in full-term neonates with CHD has been shown to be delayed, with an average brain maturation of only 35 weeks' gestation even in term infants 7
When prematurity is added to this baseline delay in brain maturation, the risk for neurodevelopmental disability increases significantly 7, 6
The American Heart Association guidelines do not specifically identify ascending aorta size of 5 mm as a major risk factor for neurodevelopmental disability, but do emphasize the importance of considering patient-specific characteristics like prematurity 7, 8